250 related articles for article (PubMed ID: 19586941)
21. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
van de Poel MH; Coebergh JW; Hillen HF
Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
[TBL] [Abstract][Full Text] [Related]
22. Differential diagnosis of monoclonal gammopathy.
Gandara DR; Mackenzie MR
Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
[TBL] [Abstract][Full Text] [Related]
23. Expression of shared idiotypes by paraproteins from patients with monoclonal gammopathy of undetermined significance.
Kampe CE; Hart S; Miller RA; Lichtenstein A; Kyle RA; Berenson JR
Br J Haematol; 1994 Aug; 87(4):719-24. PubMed ID: 7986712
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.
Caers J; Vekemans MC; Bries G; Beel K; Delrieu V; Deweweire A; Demuynck H; De Prijck B; De Samblanx H; Kentos A; Meuleman N; Mineur P; Offner F; Vande Broek I; Van Droogenbroeck J; Vande Velde A; Wu KL; Delforge M; Schots R; Doyen C;
Ann Med; 2013 Sep; 45(5-6):413-22. PubMed ID: 23767978
[TBL] [Abstract][Full Text] [Related]
25. Lympho-hemopoietic malignancies in India.
Bhutani M; Vora A; Kumar L; Kochupillai V
Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
[TBL] [Abstract][Full Text] [Related]
26. Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA.
Go RS; Heien HC; Sangaralingham LR; Habermann EB; Shah ND
Haematologica; 2018 Mar; 103(3):e123-e125. PubMed ID: 29269527
[No Abstract] [Full Text] [Related]
27. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.
Ely SA; Knowles DM
Am J Pathol; 2002 Apr; 160(4):1293-9. PubMed ID: 11943714
[TBL] [Abstract][Full Text] [Related]
28. A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders.
Basile U; Gulli F; Isgrò MA; Napodano C; Pocino K; Santini SA; Gragnani L; Conti L; Rossi E; Cordone I; Zignego AL; Rapaccini GL; Cigliana G; Berruti F; Todi L; Marino M; Di Stasio E
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4293-4302. PubMed ID: 31173301
[TBL] [Abstract][Full Text] [Related]
29. Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.
Villeneuve S; Orsi L; Monnereau A; Berthou C; Fenaux P; Marit G; Soubeyran P; Huguet F; Milpied N; Leporrier M; Hemon D; Troussard X; Clavel J
Int J Cancer; 2009 Mar; 124(5):1188-95. PubMed ID: 19058175
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
Jimenez-Zepeda VH; Heilman RL; Engel RA; Carey EJ; Freeman C; Rakela J; Mulligan DC; Fonseca R; Stewart AK
Transplantation; 2011 Sep; 92(5):570-4. PubMed ID: 21712755
[TBL] [Abstract][Full Text] [Related]
31. Transplant immunosuppression-related malignant lymphomas.
Swinnen LJ
Cancer Treat Res; 1993; 66():95-110. PubMed ID: 8102866
[No Abstract] [Full Text] [Related]
32. [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Guerci AP; Burtin P; Mattei S; Lederlin P
Ann Med Interne (Paris); 1992; 143(3):155-9. PubMed ID: 1524349
[TBL] [Abstract][Full Text] [Related]
33. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
Chappuis BB; Müller-Hermelink HK
Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
[TBL] [Abstract][Full Text] [Related]
34. [Lymphoproliferative disorders after liver transplantation].
Pageaux GP
Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
[No Abstract] [Full Text] [Related]
35. [Clinical significance of monoclonal gammopathy with undetermined significance--review].
Wang XW; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1365-9. PubMed ID: 21129295
[TBL] [Abstract][Full Text] [Related]
36. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
[TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma: clinical evaluation of plasma cell lymphoproliferative disorders and initial management.
Zulian GB
Semin Hematol; 1997 Jan; 34(1 Suppl 1):29-39. PubMed ID: 9122744
[TBL] [Abstract][Full Text] [Related]
38. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
39. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system].
Westerhausen M
Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157
[TBL] [Abstract][Full Text] [Related]
40. Ring neutrophils in plasma cell dyscrasia.
Kanoh T
Arch Pathol Lab Med; 1991 Feb; 115(2):178-80. PubMed ID: 1992987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
